24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
08/02/2018
ERC Grants & the Catalan Research System: a Success Story
01/02/2018
The best of the Bioregion of Catalonia in 2017
25/01/2018
Barcelona, a business friendly capital
18/01/2018
When Ideas Generated at the UAB make cows happy
11/01/2018
2017, the Year When Stradivarius settled Down In the Barcelona Synchrotron Park
21/12/2017
Barcelona Supercomputing Center: Beautiful, Powerful And European